The clinical trial process is broken for a variety of reasons, ranging from the difficulty of designing trial protocols to the cost of running them. But one critical (and solvable) issue is finding, ...

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...

In total, 5,251 discretized criteria were extracted from 216 protocols. The most frequent criterion was previous chemotherapy/biologics (17%). The multilabel SVM demonstrated a pooled accuracy of 75%.

While important, clinical trial protocols merely provide the foundation for success. It is the people who run those protocols, and their use of optimal processes and systems, that determine whether ...

The research industry’s approach to building clinical trial equity and inclusion has shifted, bringing a renewed focus to these goals. This is great news: Trials that more accurately represent patient ...

Jury selection is a critical part of the trial process that can impact the outcome of a case. Counsel should understand the relevant rules and strategic considerations to help shape the jury ...

Over time U.S. investments in clinical research have grown substantially, despite the fact that the rate of increase in funding slowed between 2003-2007. Industry was the largest funder of biomedical ...

Despite the availability of effective therapies for patients with chronic kidney disease, type 2 diabetes, and hypertension (the kidney-dysfunction triad), the results of large-scale trials examining ...